AU Patent

AU2013211546B1 — A Medicament

Assigned to AFT Pharmaceuticals Ltd · Expires 2013-12-19 · 12y expired

What this patent protects

A medicament for treating upper respiratory mucosal congestion, the medicament having a combination of: 5 0 approximately 2 mg to approximately 4 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine); and * app…

USPTO Abstract

A medicament for treating upper respiratory mucosal congestion, the medicament having a combination of: 5 0 approximately 2 mg to approximately 4 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine); and * approximately 250 mg to approximately 500 mg paracetamol; for providing an adult with a total dose of: 10 0 approximately 4 mg to approximately 8 mg phenylephrine hydrochloride (or an equivalent amount of a pharmaceutically acceptable alternative form of phenylephrine); and * approximately 500 mg to approximately 1,000 mg paracetamol.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013211546B1
Jurisdiction
AU
Classification
—
Expires
2013-12-19
Drug substance claim
No
Drug product claim
No
Assignee
AFT Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.